DETECTING BLADDER CANCER EARLY
Published in Journal of Translational Medicine
Charles Rosser
YOSHIKO SHIMIZU | KAZUE TSUKIKAWA HIDEKI FURUYA | CHARLES ROSSER
A non-invasive bladder cancer detection test was developed by Charles Rosser , MD , MBA , director of Translational and Clinical Research and his colleagues . The test showed a strong overall performance when used on par ticipants in Japan .
“ The development of non-invasive tests that can accurately detect and monitor bladder cancer is clinically urgent ,” said Rosser . “ With the prolonged and invasive nature of follow-up and treatment strategies , bladder cancer is one of the most expensive malignancies to manage .”
The test results confrmed the presence of bladder cancer when evaluating samples with the chosen panel of biomarkers . The results reinforced the potential use of the biomarkers for detection of the disease .
BLADDER CANCER IN HAWAI ‘ I
MOST |
MOST DEADLY |
PEOPLE ARE |
COMMON |
CANCER |
DIAGNOSED |
CANCER |
IN MEN |
EACH YEAR |
Hideki Furuya
ENZYME DISCOVERY IN COLON AND BREAST CANCERS
Published in Journal of Translational Medicine and Carcinogenesis
HIDEKI FURUYA | PAULETTE M . TAMASHIRO YOSHIKO SHIMIZU | KAYOKO IINO | RAFAEL PERES
Hideki Furuya , PhD , and collaborators found that the enzyme ( sphingosine kinase 1 ), which produces an infammatory lipid , plays an important role in colon and breast cancers . Specifcally , the most recent study found that sphingosine kinase 1 activates the immune cell ( macrophage ) to induce infammation leading to colon cancer . The fndings can potentially lead to an innovative immunotherapy for cancers in the near future .
19